Cargando…
Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer
Although human papillomavirus (HPV) positive oral and oropharyngeal cancers have distinct epidemiologic and molecular characteristics compared to HPV-negative cancers, all patients with oral and oropharyngeal cancers received same standard regimen regardless of HPV status. For these reasons, specifi...
Autores principales: | Kim, Yi Rang, Lee, Bada, Byun, Mi Ran, Lee, Jong Kil, Choi, Jin Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040768/ https://www.ncbi.nlm.nih.gov/pubmed/29995943 http://dx.doi.org/10.1371/journal.pone.0200509 |
Ejemplares similares
-
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997) -
Sexual Behaviour and Human Papillomavirus-Positive Oral Cavity and Oropharyngeal Cancer: An Irish Perspective
por: Crotty, Thomas J, et al.
Publicado: (2020) -
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019) -
Recent advances in managing human papillomavirus-positive oropharyngeal tumors
por: Cantu, Giulio, et al.
Publicado: (2010) -
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
por: Feller, Liviu, et al.
Publicado: (2010)